Faes Farma S.A. logo

Faes Farma S.A. (FFEA)

Market Closed
12 Dec, 20:00
XBER XBER
4. 76
+0.06
+1.38%
- Market Cap
- P/E Ratio
0.46% Div Yield
0 Volume
- Eps
4.7
Previous Close
Day Range
4.76 4.76
Year Range
3.23 4.76
Want to track FFEA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 75 days

Summary

FFEA closed today higher at €4.76, an increase of 1.38% from yesterday's close, completing a monthly increase of 1.6% or €0.08. Over the past 12 months, FFEA stock gained 40.41%.
FFEA is not paying dividends to its shareholders.
The last earnings report, released on Nov 07, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
Faes Farma S.A. has completed 2 stock splits, with the recent split occurring on Apr 12, 2023.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

FFEA Chart

Faes Farma S.A. (FFEA) FAQ

What is the stock price today?

The current price is €4.76.

On which exchange is it traded?

Faes Farma S.A. is listed on XFRA.

What is its stock symbol?

The ticker symbol is FFEA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.46%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Faes Farma S.A. ever had a stock split?

Faes Farma S.A. had 2 splits and the recent split was on Apr 12, 2023.

Faes Farma S.A. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
XBER Exchange
ES0134950F36 ISIN
Spain Country
1,748 Employees
3 Jul 2025 Last Dividend
12 Apr 2023 Last Split
- IPO Date

Overview

Faes Farma, S.A. is a distinguished pharmaceutical entity engaged in the investigation, development, production, and distribution of pharmaceutical formulations and raw materials on both a national and international level. Established in 1933 and headquartered in Leioa, Spain, the company has carved a niche in the pharmaceutical industry through its extensive range of products that cater to various health needs. These products encompass prescription and generic drugs, over-the-counter (OTC) medications, dietary supplements, infant nutrition, and a variety of other health-related products. In addition to its wide range of human pharmaceuticals, Faes Farma also ventures into the domain of animal nutrition and health, showcasing its versatility and commitment to improving health across different spectrums. The company's extensive distribution network ensures its presence in the global market, demonstrating its role as a key player in the pharmaceutical field.

Products and Services

Faes Farma's portfolio comprises an extensive array of products designed to meet diverse healthcare needs:

  • Actimag: A supplement of magnesium pidolate, aims to address magnesium deficiencies.
  • Bilaxten: An anti-allergic medication designed to alleviate allergies.
  • Bronquidiazina CR: An anti-infective drug for treating infections.
  • Claversal: Used in the management of ulcerative colitis and Crohn's disease.
  • Dezacor: A corticoid, offering relief in conditions requiring corticosteroids.
  • Dolotren: An anti-inflammatory drug aimed at reducing inflammation and pain.
  • Dolotren Gel: A topical formulation providing localized relief from pain and inflammation.
  • Dynamogen: An anti-anorexic medication designed to stimulate appetite.
  • Ferroprotina: An anti-anaemic agent for treating iron deficiency anaemia.
  • Hidroferol: Plays a role in managing certain conditions related to bone metabolism.
  • Lipofen, Positon: Medications focusing on dermatitis and lipid management respectively.
  • Potenciator and Surmenalit: Products aimed at enhancing strength and vitality.
  • Pruina: A laxative designed to ease constipation.
  • Robaxisal Compuesto: A combination muscle relaxant and analgesic for muscle pain relief.
  • Trausan: Contains citicoline, used for neurological recovery.
  • Yendol: An anti-flu medication, aimed at combating influenza symptoms.
  • Bilastine: An innovative antihistamine molecule for treating allergic rhinoconjunctivitis and urticaria.
  • Calcifediol: Focused on improving bone metabolism issues.
  • Deflazacort: Targets osteoarticular diseases, offering relief and treatment.
  • Hidrosmin: A medication for venous insufficiency, improving vein health.
  • Mesalazine: Dedicated to addressing digestion problems associated with inflammatory bowel diseases.

In addition to human health products, Faes Farma also extends its expertise to animal nutrition and health, emphasizing its commitment to overall wellness.

Contact Information

Address: Avenida AutonomIa 10
Phone: 34 944 81 83 00